Novo Nordisk A S (NVO) — 6-K Filings

All 6-K filings from Novo Nordisk A S. Browse 7 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (7)

Novo Nordisk Files Routine 6-K Report — Apr 20, 2026 Risk: low
Novo Nordisk A/S filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself
Novo Nordisk Files Routine 6-K Report — Apr 20, 2026 Risk: low
Novo Nordisk A/S filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself
6-K Filing — Apr 13, 2026
6-K Filing — Apr 7, 2026
Novo Nordisk Files 6-K Report — Mar 27, 2026 Risk: low
Novo Nordisk A/S filed a Form 6-K on March 27, 2026, reporting information as a foreign issuer. The filing includes various documents, primarily graphic files,
Novo Nordisk Files 6-K Report — Mar 27, 2026 Risk: low
Novo Nordisk A/S filed a Form 6-K on March 27, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself
Novo Nordisk Files Routine 6-K Report on March 26, 2026 — Mar 26, 2026
Novo Nordisk A/S filed a 6-K report on March 26, 2026, indicating a routine foreign issuer report. This filing, with accession number 0001171843-26-001932, prov

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX